Loading people...
Craig Frances is a Managing Director at Summit Partners, a global growth equity firm. He specializes in growth equity investments, particularly within the healthcare and technology sectors, bringing a unique blend of medical and financial expertise to his role.
Craig Frances primarily invests in high-growth companies within the healthcare and technology sectors. His specific focus areas include healthcare services, healthcare IT, and technology-enabled services, where he seeks to partner with innovative businesses.
Craig Frances works as a Managing Director at Summit Partners, a leading growth equity firm with offices globally. He joined Summit Partners in 2007 and has been a key member of their investment team ever since.
Craig Frances is a Managing Director at Summit Partners based in Menlo Park, California, where he co-heads the firm's healthcare and life sciences investment team. Before joining the growth equity firm in 2003, he completed his medical residency at the University of California, San Francisco, and founded three companies, including The .tv Corporation International, which was acquired by Verisign. Over his twenty-year investing career, Frances has served on more than 30 corporate boards and guided numerous portfolio companies to successful public offerings and acquisitions. His notable transactions include the acquisitions of Integrated DNA Technologies by Danaher, BluePearl Veterinary Services by Mars Petcare, and Healthline Media by Red Ventures. As a former practicing physician who earned his medical degree as valedictorian from Cornell University, Frances focuses on scaling high-growth healthcare services, medical devices, and healthcare technology businesses.
Craig Frances serves as a Managing Director at Summit Partners, a leading global growth equity firm. In this pivotal role, he is instrumental in sourcing, evaluating, and executing growth equity investments, primarily concentrating on the dynamic healthcare and technology sectors. His investment focus is particularly keen on healthcare services, healthcare IT, and technology-enabled services, where he seeks out innovative companies poised for significant expansion.
Frances brings a unique and comprehensive perspective to his investment strategies, rooted in both extensive business acumen and a strong medical background. Prior to joining Summit Partners in 2007, he honed his strategic consulting skills at McKinsey & Company, where he was a key member of their healthcare practice. This experience provided him with invaluable insights into the operational and market dynamics of the healthcare industry. Before his career in finance and consulting, Craig Frances practiced medicine as an internal medicine physician at Stanford University Medical Center, giving him a firsthand understanding of clinical needs and healthcare delivery systems. This blend of medical expertise and financial insight allows him to identify and support companies that are not only financially promising but also address critical market demands and improve patient outcomes.
Throughout his tenure at Summit Partners, Craig Frances has been involved with numerous successful investments, demonstrating his ability to partner with visionary entrepreneurs and drive substantial growth. Notable investments include his involvement with companies such as Signify Health (NYSE: SGFY), a leading healthcare platform that connects payors, providers, and patients to achieve better health outcomes; Lincare (NASDAQ: LNCR), a major provider of in-home respiratory and durable medical equipment services; and Press Ganey (NYSE: PGND), a recognized leader in patient experience and healthcare performance improvement. His portfolio reflects a consistent track record of identifying market leaders and fostering their development through strategic guidance and capital investment.
Craig Frances holds an MD from the University of California, San Francisco, an MBA from Harvard Business School, and a BA from Dartmouth College. His diverse educational background and professional journey underscore his multifaceted approach to growth equity investing, making him a respected figure in both the investment and healthcare communities. He continues to seek out and support companies that are transforming their respective industries.
